Could these FTSE 100 giants boost your portfolio higher?

Should you be buying these three FTSE 100 (INDEXFTSE: UKX) stocks for their income potential?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

FTSE 100 (INDEXFTSE: UKX) stocks can provide great returns for investors. Through income and growth the stocks can be a stable way to get rich slowly. 

Commodity giant

Glencore (LSE: GLEN) has been under the spotlight for over a year now. Commodity prices across the board fell sharply, which dragged the share price of Glencore down to all-time lows. However, since then the company has done a lot counter criticism of its business and it has come a long way since City analysts were saying it could go to zero. Since 1 January the share price has climbed 125% and analysts are now tagging the stock with price targets over 250p. The company has looked at the issue of its debt pile and divested a number of assets to pay off debt. I believe that the major mining company could be a good way to ride strengthening commodity prices that many expect in the next few years. The stock is coming from a very low price so it could see an explosive price rise soon. 

Defensive pharma

GlaxoSmithKline (LSE: GSK) is a favorite of UK income fund managers and quite rightly so. It holds great defensive qualities and I believe it has less risk than its FTSE 100 peer AstraZeneca. Glaxo shares are currently yielding over 4%, which is a decent income considering we live in a world of low interest rates. For income investors this looks like a top stock to own for its dividend and growth potential. The pipeline of new drugs that Glaxo has is very encouraging and the company believes there could be multiple blockbuster drugs on the way. This pipeline will add to profitability for the firm. While currently the shares are trading on 17 times forward price-to-earnings, Glaxo looks set to reap the rewards of its R&D success and I think the shares look cheap. 

UK housebuilding play

Persimmon (LSE: PSN) is about to become a great income stock due to the huge dividend scheme the company is about to begin. The shares are on a yield of over 5% and have nearly recovered since the Brexit vote shock. The UK has a fundamental housing shortage, which was addressed by Chancellor Philip Hammond this week. When setting out his new £5bn housing fund he said “my message today is clear: it’s time to get building”. This fund is for small businesses to build 25,000 homes by 2020 and 225,000 in the longer term. This is a clear indication that the housebuilding sector in the UK has a lot of work to do. Persimmon is a great way to play housebuilding in the UK and receive some income at the same time. 

I believe that these three giants will provide investors with good capital growth over the next few years and should outperform the wider market. In the case of Glaxo and Persimmon, investors will receive some chunky dividend payouts too. 

Jack Dingwall has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

£10,000 buys 373 shares in this FTSE 100 heavyweight that’s tipped to surve in 2026

With analysts expecting the stock to climb 54% in the next 12 months, is now the perfect time for investors…

Read more »

This way, That way, The other way - pointing in different directions
Investing Articles

Are BP shares a slam-dunk buy as oil prices rocket – or is there a hidden danger?

As the oil price rises, investors might expect BP shares to follow. But Harvey Jones warns it may not play…

Read more »

Investing Articles

2 growth stocks to consider buying for an ISA in March

Here are two growth stocks I think are worth considering buying. Both have stumbled recently, even though the underlying businesses…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

How long might a Stocks and Shares ISA take to earn a £950 monthly second income?

Christopher Ruane explains how someone could seek to turn a Stocks and Shares ISA into a source of monthly passive…

Read more »

British pound data
Investing Articles

Get yourself ready for a violent stock market crash!

The FTSE 100 is sinking, raising fears of a fresh stock market crash. What are you doing about it? Here's…

Read more »

ISA Individual Savings Account
Investing Articles

Hands up, who’s dreaming of a million in a Stocks and Shares ISA?

How to make a million in a Stocks and Shares ISA, that's what headlines keep banging on about. Let's look…

Read more »

British Pennies on a Pound Note
Investing Articles

OK, who’s dreaming of making a million from red-hot penny shares?

Investors in penny shares can sound like the most upbeat optimists there are. It can work, but hopes need to…

Read more »

Three generation family are playing football together in a field. There are two boys, their father and their grandfather.
Investing Articles

Could this ultra-high-yielding FTSE 100 passive income gem quietly fund my retirement?

With rising payouts, strong cash generation and impressive earnings forecasts, this FTSE 100 dividend gem may be developing into a…

Read more »